Clinical Trial Update: A Study of LY3164530 in Participants With Cancer [Phase 1]

View source ↗

Summary

Phase 1 study of LY3164530 in participants with cancer completed; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Metastasis
• Neoplasms

Drugs mentioned

• LY3164530

Snippet

Sponsor: Eli Lilly and Company | Conditions: Neoplasms, Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2019-10-23